Diabetes Mellitus, Type 2
72 treatments and conditions followed through the public trial records. Not medical advice.How a status is set
Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| AI-Guided Multimodal Rehabilitation Program for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Aminohippurate Sodium Inj 20% + CANAGLIFLOZIN for diabetes mellitus, type 2 | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| ATR-258 for diabetes mellitus, type 2 | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| AZD6234 for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Berberine ursodeoxycholate for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 6 |
| Berobenatide for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Cagrilintide for diabetes mellitus, type 2 | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Calorie restriction via total food replacement for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| cfMSC therapy for diabetes for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Clazakizumab for diabetes mellitus, type 2 | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Clofutriben for diabetes mellitus, type 2 | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Continous Glucose Monitor (CGM) + Low-calorie diet + Personalized exercise program for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Dapagliflozin + Elecoglipron for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Dexcom G6 Professional Continuous Glucose Monitor + INSULIN HUMAN for diabetes mellitus, type 2 | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Dexcom G6 Professional Continuous Glucose Monitor + Sliding Scale Insulin for diabetes mellitus, type 2 | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Dexcom G6 Professional Continuous Glucose Monitor + Up-Titration of Home Insulin for diabetes mellitus, type 2 | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| digital prosthetic interface technology for diabetes mellitus, type 2 | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| DMR Procedure for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| DMR Procedure (Fractyl) for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Dulaglutide for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Elecoglipron for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 4 |
| Eloralintide for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 4 |
| Eloralintide + Macupatide for diabetes mellitus, type 2 | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| eloralintide and tirzepatide for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Empagliflozin for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Exploratory test group for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Food Security Screening & Referral Program for diabetes mellitus, type 2 | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Food-based diet for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Formula diet for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| HD-6277 100mg for diabetes mellitus, type 2 | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| HD-6277 25mg for diabetes mellitus, type 2 | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| HD-6277 50mg for diabetes mellitus, type 2 | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| High-dose LC-Z300-01 twice daily in blinding for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| HS-20094 Injection for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| icovamenib 100 mg for diabetes mellitus, type 2 | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| icovamenib 100mg for diabetes mellitus, type 2 | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Insulin efsitora alfa for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 12 |
| Intensive lifestyle Intervention for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Intensive lifestyle Intervention + Meal replacement system for diabetes mellitus, type 2 | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Intermittent energy restriction (IER) for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Intermittent fasting 5:2 + Low-carbohydrate diet + Total diet replacement for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| K-757 and K-833 for diabetes mellitus, type 2 | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| K-757 and K-833 BID + K-757 and K-833 QD for diabetes mellitus, type 2 | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Liraglutide for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Low-calorie MIND-HK diet for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Low-dose LC-Z300-01 twice daily in blinding for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Macupatide for diabetes mellitus, type 2 | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Maridebart Cafraglutide for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| MKP10241 for diabetes mellitus, type 2 | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Oral appliance therapy for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Orforglipron for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 15 |
| PF-08653944 for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| PG-102 for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Relacorilant for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Retatrutide for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 10 |
| Semaglutide for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 7 |
| Semaglutide + Cagrilintide for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Structured weight-loss program for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Survodutide for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Test group for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Tifeglipron for diabetes mellitus, type 2 | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Time Restricted Eating (TRE) for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Time Restricted Eating As Treatment (TREAT) for Diabetes. for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Time restricted feeding for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Time-restricted eating for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Tirzepatide for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 5 |
| Total Diet Replacement for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Total Diet Replacement (800kcal/day) for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Total Diet Replacement (TDR) Program for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Very Low-calorie MIND-HK diet for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Vicadrostat for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Zenagamtide for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |